MARKET PULSE-Chelsea Therapeutics, Herbalife, Colgate, Garmin, Zale

Wed Feb 19, 2014 7:47am EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(For more market insights, including options activity, click on ; for the Day Ahead newsletter; for the Morning News Call newsletter, U.S. stock index futures fell on Wednesday. Dow Jones industrial average futures were down 0.04 percent at 16,101, S&P 500 futures were down 0.33 percent at 1,831.3 and Nasdaq 100 futures were down 0.22 percent at 3,666.75.

** CHELSEA THERAPEUTICS INTERNATIONAL LTD, Tuesday close $4.95, +36.16 pct premarket

The company's drug Northera, which treats a rare form of low blood pressure associated with neurological disorders such as Parkinson's disease, has won U.S. approval, the Food and Drug Administration said on Tuesday.

** SIGNET JEWELERS LTD, Tuesday close $79.27, +13.85 pct premarket

** ZALE CORP, Tuesday close $14.91, +40.17 pct premarket

Kay Jewelers parent Signet Jewelers said it would acquire smaller rival Zale Corp for $21 per share in cash, valuing the mid-tier jeweler at about $690 million.

The offer represents a premium of about 41 percent to Zale's close of $14.91 on the New York Stock Exchange on Tuesday.   Continued...